ArticleInternational journal of hematology2006

Oral administration of imatinib to P230 BCR/ABL-expressing transgenic mice changes clones with high BCR/ABL complementary DNA expression into those with low expression.

Mitsuharu Inami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.